10x Genomics, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
10x Genomics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • 10x Genomics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$41.5M, a 56.2% increase year-over-year.
  • 10x Genomics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$200M, a 14.3% increase year-over-year.
  • 10x Genomics, Inc. annual Operating Income (Loss) for 2023 was -$265M, a 58% decline from 2022.
  • 10x Genomics, Inc. annual Operating Income (Loss) for 2022 was -$168M, a 221% decline from 2021.
  • 10x Genomics, Inc. annual Operating Income (Loss) for 2021 was -$52.3M, a 90.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$265M -$97.4M -58% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$168M -$116M -221% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$52.3M +$482M +90.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$534M -$504M -1647% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 -$30.6M +$80.2M +72.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$111M -$92.4M -503% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$18.4M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.